Comera Life Sciences Holdings Inc (CMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 147 | 95 | 161 | 88 | 71 |
| Cost of Goods | 55 | 45 | 55 | 48 | 58 |
| Gross Profit | 92 | 51 | 106 | 39 | 13 |
| Operating Expenses | 4,120 | 2,548 | 2,642 | 1,002 | 1,975 |
| Operating Income | -3,973 | -2,453 | -2,480 | -914 | -1,904 |
| Other Income | -5,112 | -427 | -4,325 | 0 | -77 |
| Pre-tax Income | -9,085 | -2,879 | -6,805 | -914 | -1,981 |
| Net Income Continuous | -9,085 | -2,879 | -6,805 | -914 | -1,981 |
| Net Income | $-9,085 | $-2,879 | $-6,805 | $-914 | $-1,981 |
| EPS Basic Total Ops | -1.14 | -4.01 | 4.89 | -6.34 | -0.68 |
| EPS Basic Continuous Ops | -1.12 | -4.01 | 3.70 | -6.35 | -0.68 |
| EPS Diluted Total Ops | -1.14 | -4.01 | 4.89 | -6.34 | -0.68 |
| EPS Diluted Continuous Ops | -1.12 | -4.01 | 3.70 | -6.35 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -1.32 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-3,951 | $-2,428 | $-2,456 | $-895 | $-1,904 |